APO Research
Talk to an analyst

APO RESEARCH · REPORT

T Cell Surface Glycoprotein CD3 Epsilon

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global T Cell Surface Glycoprotein CD3 Epsilon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025188 pages

Choose your research edition.

Industry ResearchT Cell Surface Glycoprotein CD3 Epsilon Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal T Cell Surface Glycoprotein CD3 Epsilon Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal T Cell Surface Glycoprotein CD3 Epsilon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal T Cell Surface Glycoprotein CD3 Epsilon Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal T Cell Surface Glycoprotein CD3 Epsilon Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global T Cell Surface Glycoprotein CD3 Epsilon market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for T Cell Surface Glycoprotein CD3 Epsilon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for T Cell Surface Glycoprotein CD3 Epsilon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for T Cell Surface Glycoprotein CD3 Epsilon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for T Cell Surface Glycoprotein CD3 Epsilon is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of T Cell Surface Glycoprotein CD3 Epsilon include GlaxoSmithKline Plc, Amgen Inc, Tiziana Life Sciences Plc, SYNIMMUNE GmbH, Numab Innovation AG, Meridigen Biotech Co Ltd, MacroGenics Inc, F. Hoffmann-La Roche Ltd and Celgene Corp, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global T Cell Surface Glycoprotein CD3 Epsilon market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of T Cell Surface Glycoprotein CD3 Epsilon and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents T Cell Surface Glycoprotein CD3 Epsilon revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the T Cell Surface Glycoprotein CD3 Epsilon market size, projected growth trends, production technologies, key applications, and end-use industries.

T Cell Surface Glycoprotein CD3 Epsilon Segment by Company

GlaxoSmithKline Plc

Amgen Inc

Tiziana Life Sciences Plc

SYNIMMUNE GmbH

Numab Innovation AG

Meridigen Biotech Co Ltd

MacroGenics Inc

F. Hoffmann-La Roche Ltd

Celgene Corp

T Cell Surface Glycoprotein CD3 Epsilon Segment by Type

ND-007

Foralumab

Coltelizumab

AVA-002

Others

T Cell Surface Glycoprotein CD3 Epsilon Segment by Application

Autoimmune Disorders

Hepatitis B

Prostate Cancer

Multiple Sclerosis

Others

T Cell Surface Glycoprotein CD3 Epsilon Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global T Cell Surface Glycoprotein CD3 Epsilon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of T Cell Surface Glycoprotein CD3 Epsilon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of T Cell Surface Glycoprotein CD3 Epsilon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of T Cell Surface Glycoprotein CD3 Epsilon in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global T Cell Surface Glycoprotein CD3 Epsilon industry.

Chapter 3: Detailed analysis of T Cell Surface Glycoprotein CD3 Epsilon companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, T Cell Surface Glycoprotein CD3 Epsilonrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of ND-007 Table 3. Key Players of Foralumab Table 4. Key Players of Coltelizumab Table 3. Key Players of AVA-002 Table 4. Key Players of Others Table 5. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Autoimmune Disorders Table 7. Key Players of Hepatitis B Table 8. Key Players of Prostate Cancer Table 9. Key Players of Multiple Sclerosis Table 10. Key Players of Others Table 11. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region (2021-2026) & (US$ Million) Table 13. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Region (2021-2026) Table 14. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region (2027-2032) & (US$ Million) Table 15. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Region (2027-2032) Table 16. T Cell Surface Glycoprotein CD3 Epsilon Industry Trends Table 17. T Cell Surface Glycoprotein CD3 Epsilon Industry Drivers Table 18. T Cell Surface Glycoprotein CD3 Epsilon Industry Opportunities and Challenges Table 19. T Cell Surface Glycoprotein CD3 Epsilon Industry Restraints Table 20. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue by Company (US$ Million) & (2021-2026) Table 21. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue Market Share by Company (2021-2026) Table 22. Global T Cell Surface Glycoprotein CD3 Epsilon Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global T Cell Surface Glycoprotein CD3 Epsilon Key Company Head Office and Area Served Table 24. Global T Cell Surface Glycoprotein CD3 Epsilon Company, Product Type & Application Table 25. Global T Cell Surface Glycoprotein CD3 Epsilon Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global T Cell Surface Glycoprotein CD3 Epsilon by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026) & (US$ Million) Table 30. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032) & (US$ Million) Table 31. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue Market Share by Type (2021-2026) Table 32. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue Market Share by Type (2027-2032) Table 33. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026) & (US$ Million) Table 35. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032) & (US$ Million) Table 36. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue Market Share by Application (2021-2026) Table 37. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue Market Share by Application (2027-2032) Table 38. GlaxoSmithKline Plc Company Information Table 39. GlaxoSmithKline Plc Business Overview Table 40. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 42. GlaxoSmithKline Plc Recent Development Table 43. Amgen Inc Company Information Table 44. Amgen Inc Business Overview Table 45. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 47. Amgen Inc Recent Development Table 48. Tiziana Life Sciences Plc Company Information Table 49. Tiziana Life Sciences Plc Business Overview Table 50. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 52. Tiziana Life Sciences Plc Recent Development Table 53. SYNIMMUNE GmbH Company Information Table 54. SYNIMMUNE GmbH Business Overview Table 55. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 57. SYNIMMUNE GmbH Recent Development Table 58. Numab Innovation AG Company Information Table 59. Numab Innovation AG Business Overview Table 60. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 62. Numab Innovation AG Recent Development Table 63. Meridigen Biotech Co Ltd Company Information Table 64. Meridigen Biotech Co Ltd Business Overview Table 65. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 67. Meridigen Biotech Co Ltd Recent Development Table 68. MacroGenics Inc Company Information Table 69. MacroGenics Inc Business Overview Table 70. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 72. MacroGenics Inc Recent Development Table 73. F. Hoffmann-La Roche Ltd Company Information Table 74. F. Hoffmann-La Roche Ltd Business Overview Table 75. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 77. F. Hoffmann-La Roche Ltd Recent Development Table 78. Celgene Corp Company Information Table 79. Celgene Corp Business Overview Table 80. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio Table 82. Celgene Corp Recent Development Table 83. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026) & (US$ Million) Table 84. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032) & (US$ Million) Table 85. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026) & (US$ Million) Table 86. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032) & (US$ Million) Table 87. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 88. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026) Table 89. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2027-2032) Table 90. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026) & (US$ Million) Table 91. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032) & (US$ Million) Table 92. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026) & (US$ Million) Table 93. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032) & (US$ Million) Table 94. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026) Table 96. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2027-2032) Table 97. China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026) & (US$ Million) Table 98. China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032) & (US$ Million) Table 99. China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026) & (US$ Million) Table 100. China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032) & (US$ Million) Table 101. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026) & (US$ Million) Table 102. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032) & (US$ Million) Table 103. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026) & (US$ Million) Table 104. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032) & (US$ Million) Table 105. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026) Table 107. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2027-2032) Table 108. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026) & (US$ Million) Table 109. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032) & (US$ Million) Table 110. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026) Table 114. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2027-2032) Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. T Cell Surface Glycoprotein CD3 Epsilon Product Image Figure 2. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type: 2025 VS 2032 Figure 4. ND-007 Image Figure 5. Foralumab Image Figure 6. Coltelizumab Image Figure 7. AVA-002 Image Figure 8. Others Image Figure 9. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application: 2025 VS 2032 Figure 11. Autoimmune Disorders Image Figure 12. Hepatitis B Image Figure 13. Prostate Cancer Image Figure 14. Multiple Sclerosis Image Figure 15. Others Image Figure 16. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 18. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global T Cell Surface Glycoprotein CD3 Epsilon Market Share by Players in 2025 Figure 21. Global Top 5 and 10 T Cell Surface Glycoprotein CD3 Epsilon Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue Market Share by Type (2021-2032) Figure 25. Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global T Cell Surface Glycoprotein CD3 Epsilon Revenue Market Share by Application (2021-2032) Figure 27. North America T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 28. North America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032) Figure 29. North America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032) Figure 30. North America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032) Figure 31. United States T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 32. Canada T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 33. Mexico T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 34. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 35. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032) Figure 36. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032) Figure 37. Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032) Figure 38. Germany T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 39. France T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 40. U.K. T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 41. Italy T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 42. Russia T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 44. China T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 45. China T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032) Figure 46. China T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032) Figure 47. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 48. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032) Figure 49. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032) Figure 50. Asia T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032) Figure 51. Japan T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 52. South Korea T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 55. India T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 56. Australia T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032) Figure 61. Brazil T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 62. South Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 64. Turkey T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 65. Argentina T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 66. UAE T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 67. Egypt T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 68. Chile T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • ND-007
  • Foralumab
  • Coltelizumab
  • AVA-002
  • Others
Applications
  • Autoimmune Disorders
  • Hepatitis B
  • Prostate Cancer
  • Multiple Sclerosis
  • Others
Companies covered
  • GlaxoSmithKline Plc
  • Amgen Inc
  • Tiziana Life Sciences Plc
  • SYNIMMUNE GmbH
  • Numab Innovation AG
  • Meridigen Biotech Co Ltd
  • MacroGenics Inc
  • F. Hoffmann-La Roche Ltd
  • Celgene Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 ND-007
  5. 1.2.3 Foralumab
  6. 1.2.4 Coltelizumab
  7. 1.2.5 AVA-002
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Autoimmune Disorders
  12. 1.3.3 Hepatitis B
  13. 1.3.4 Prostate Cancer
  14. 1.3.5 Multiple Sclerosis
  15. 1.3.6 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global T Cell Surface Glycoprotein CD3 Epsilon Growth Trends by Region
  18. 1.5.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region (2021-2026)
  20. 1.5.3 T Cell Surface Glycoprotein CD3 Epsilon Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global T Cell Surface Glycoprotein CD3 Epsilon Market Dynamics
  1. 2.1 T Cell Surface Glycoprotein CD3 Epsilon Industry Trends
  2. 2.2 T Cell Surface Glycoprotein CD3 Epsilon Industry Drivers
  3. 2.3 T Cell Surface Glycoprotein CD3 Epsilon Industry Opportunities and Challenges
  4. 2.4 T Cell Surface Glycoprotein CD3 Epsilon Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global T Cell Surface Glycoprotein CD3 Epsilon Revenue by Company (2021-2026)
  2. 3.2 Global T Cell Surface Glycoprotein CD3 Epsilon Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global T Cell Surface Glycoprotein CD3 Epsilon Key Company Head office and Area Served
  4. 3.4 Global T Cell Surface Glycoprotein CD3 Epsilon Company, Product Type & Application
  5. 3.5 Global T Cell Surface Glycoprotein CD3 Epsilon Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 T Cell Surface Glycoprotein CD3 Epsilon Players Market Share by Revenue in 2025
  9. 3.6.3 2025 T Cell Surface Glycoprotein CD3 Epsilon Tier 1, Tier 2, and Tier 3
4 T Cell Surface Glycoprotein CD3 Epsilon Market by Type
  1. 4.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2032)
  3. 4.3 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Type (2021-2032)
5 T Cell Surface Glycoprotein CD3 Epsilon Market by Application
  1. 5.1 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2032)
  3. 5.3 Global T Cell Surface Glycoprotein CD3 Epsilon Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GlaxoSmithKline Plc
  2. 6.1.1 GlaxoSmithKline Plc Company Information
  3. 6.1.2 GlaxoSmithKline Plc Business Overview
  4. 6.1.3 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 GlaxoSmithKline Plc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  6. 6.1.5 GlaxoSmithKline Plc Recent Developments
  7. 6.2 Amgen Inc
  8. 6.2.1 Amgen Inc Company Information
  9. 6.2.2 Amgen Inc Business Overview
  10. 6.2.3 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Amgen Inc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  12. 6.2.5 Amgen Inc Recent Developments
  13. 6.3 Tiziana Life Sciences Plc
  14. 6.3.1 Tiziana Life Sciences Plc Company Information
  15. 6.3.2 Tiziana Life Sciences Plc Business Overview
  16. 6.3.3 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Tiziana Life Sciences Plc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  18. 6.3.5 Tiziana Life Sciences Plc Recent Developments
  19. 6.4 SYNIMMUNE GmbH
  20. 6.4.1 SYNIMMUNE GmbH Company Information
  21. 6.4.2 SYNIMMUNE GmbH Business Overview
  22. 6.4.3 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 SYNIMMUNE GmbH T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  24. 6.4.5 SYNIMMUNE GmbH Recent Developments
  25. 6.5 Numab Innovation AG
  26. 6.5.1 Numab Innovation AG Company Information
  27. 6.5.2 Numab Innovation AG Business Overview
  28. 6.5.3 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Numab Innovation AG T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  30. 6.5.5 Numab Innovation AG Recent Developments
  31. 6.6 Meridigen Biotech Co Ltd
  32. 6.6.1 Meridigen Biotech Co Ltd Company Information
  33. 6.6.2 Meridigen Biotech Co Ltd Business Overview
  34. 6.6.3 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Meridigen Biotech Co Ltd T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  36. 6.6.5 Meridigen Biotech Co Ltd Recent Developments
  37. 6.7 MacroGenics Inc
  38. 6.7.1 MacroGenics Inc Company Information
  39. 6.7.2 MacroGenics Inc Business Overview
  40. 6.7.3 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 MacroGenics Inc T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  42. 6.7.5 MacroGenics Inc Recent Developments
  43. 6.8 F. Hoffmann-La Roche Ltd
  44. 6.8.1 F. Hoffmann-La Roche Ltd Company Information
  45. 6.8.2 F. Hoffmann-La Roche Ltd Business Overview
  46. 6.8.3 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 F. Hoffmann-La Roche Ltd T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  48. 6.8.5 F. Hoffmann-La Roche Ltd Recent Developments
  49. 6.9 Celgene Corp
  50. 6.9.1 Celgene Corp Company Information
  51. 6.9.2 Celgene Corp Business Overview
  52. 6.9.3 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Celgene Corp T Cell Surface Glycoprotein CD3 Epsilon Product Portfolio
  54. 6.9.5 Celgene Corp Recent Developments
7 North America
  1. 7.1 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032)
  2. 7.2 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type
  3. 7.2.1 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026)
  4. 7.2.2 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032)
  5. 7.2.3 North America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032)
  6. 7.3 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application
  7. 7.3.1 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026)
  8. 7.3.2 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032)
  9. 7.3.3 North America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032)
  10. 7.4 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country
  11. 7.4.1 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026)
  13. 7.4.3 North America T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2027-2032)
  14. 7.4.4 North America T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032)
  2. 8.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type
  3. 8.2.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026)
  4. 8.2.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032)
  5. 8.2.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032)
  6. 8.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application
  7. 8.3.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026)
  8. 8.3.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032)
  9. 8.3.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032)
  10. 8.4 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country
  11. 8.4.1 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026)
  13. 8.4.3 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2027-2032)
  14. 8.4.4 Europe T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032)
  2. 9.2 China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type
  3. 9.2.1 China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026)
  4. 9.2.2 China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032)
  5. 9.2.3 China T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032)
  6. 9.3 China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application
  7. 9.3.1 China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026)
  8. 9.3.2 China T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032)
  9. 9.3.3 China T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032)
  2. 10.2 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type
  3. 10.2.1 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026)
  4. 10.2.2 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032)
  5. 10.2.3 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032)
  6. 10.3 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application
  7. 10.3.1 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026)
  8. 10.3.2 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032)
  9. 10.3.3 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032)
  10. 10.4 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country
  11. 10.4.1 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026)
  13. 10.4.3 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2027-2032)
  14. 10.4.4 Asia T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type
  3. 11.2.1 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application
  7. 11.3.1 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country
  11. 11.4.1 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa T Cell Surface Glycoprotein CD3 Epsilon Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst